miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant PathwayLiang Shi, Fang Zheng, Jianrong Yang et al.|Asian Pacific Journal of Cancer Prevention|2015Cited by 89
Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese PatientsLiang Shi, Xiangyang Lin, Li Wu et al.|Asian Pacific Journal of Cancer Prevention|2014Cited by 22